drugset

drugset / Trial / NCT06087588

Pericapsular Nerve Group Block Chemical Neurolysis in Advanced Hip Osteoarthritis

NCT06087588 ↗

Phase 4 Completed 100 enrolled Poznan University of Medical Sciences

RandomizedParallel-groupTriple-blindTreatment

Summary

PENG neurolysis in advanced osteoarthritis of the hip joint.

Timeline

Start: 2023-10-17
Primary completion: 2025-01-10
Completion: 2025-01-14

Publications

Reysner M, Reysner T, Kowalski G, Mularski A, Daroszewski P, Wieczorowska-Tobis K. Chemical ablation of pericapsular nerve group with 95% ethanol for pain relief and quality of life in patients with hip osteoarthritis: a prospective, double-blinded, randomised, controlled trial. Br J Anaesth. 2025 Aug;135(2):382-389. doi: 10.1016/j.bja.2025.04.045. Epub 2025 Jun 6.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Alcohol	Other / unclassified	2.5 ml	—

Indications